Anzeige
Mehr »
Mittwoch, 08.07.2026 - Börsentäglich über 12.000 News
Durchbruch in Nevada: Kupfer mit bloßem Auge sichtbar!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 940602 | ISIN: NL0000009538 | Ticker-Symbol: PHI1
Tradegate
08.07.26 | 15:24
24,390 Euro
-1,53 % -0,380
1-Jahres-Chart
KONINKLIJKE PHILIPS NV Chart 1 Jahr
5-Tage-Chart
KONINKLIJKE PHILIPS NV 5-Tage-Chart
RealtimeGeldBriefZeit
24,32024,33016:07
24,28024,30015:47
GlobeNewswire (Europe)
230 Leser
Artikel bewerten:
(1)

Royal Philips: Philips introduces Alturion ultrasound system with AI-powered workflows for high-volume clinical environments

July 8, 2026

Newest addition to the Philips ultrasound portfolio, Alturion recently received FDA 510(k) clearance and CE mark, expanding access to advanced imaging and workflow innovation across clinical settings

Amsterdam, the Netherlands -Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the Alturion ultrasound system with AI-powered workflow built for high-volume settings. Available in the USA and Europe following FDA 510(k) clearance and CE mark certification, Alturion helps clinicians work more efficiently, deliver consistent results, and make confident clinical decisions.

As healthcare providers manage growing demand and increasing operational complexity, ultrasound teams need solutions that help improve efficiency without compromising quality. With the introduction of Alturion, Philips expands its ultrasound portfolio by bringing together advanced imaging, AI-powered workflows and a connected ecosystem that is designed to help streamline examinations and support consistency across users and clinical settings.

"At Philips, our goal is to develop technology that adapts to the realities of modern healthcare and helps care teams work more effectively in increasingly demanding clinical environments," said Jie Xue, Chief Business Leader, Precision Diagnosis at Philips. "Alturion was designed with that goal in mind, helping healthcare providers deliver high-quality care with greater efficiency and confidence."

Performance and usability across care settings
Alturion's powerful processing architecture supports responsive performance and clear visualization across patients and exam types. With an expansive 24-inch monitor and a small footprint, the system enables easy movement from department to bedside and supports space utilization. Streamlined, intuitive workflows help reduce manual adjustments and exam time, helping providers manage high patient volumes, while a familiar user interface supports operational simplicity and consistency across care teams.

Alturion is the newest ultrasound system to include Elevate Plus with AI-powered measurements for abdominal ultrasound. AI-enabled capabilities help streamline acquisition, automate measurements, and support reproducibility. By helping reduce variability and save time, these tools can contribute to more consistent exams and support clinical decision-making.

A connected ultrasound ecosystem
Alturion fits within Philips' connected ultrasound ecosystem, sharing a common user interface and interchangeable transducers that are compatible with EPIQ Elite and Affiniti systems. By enabling sonographers and clinicians to use the same transducers across multiple systems, healthcare organizations can help simplify training, accelerate onboarding and support consistent workflows across departments. Philips' complete general imaging ultrasound portfolio is designed for upgradeability and is compatible with Collaboration Live, a tele-ultrasound capability that enables multiple users to connect in real time for remote support, training and consultation.

For more information on Alturion, please visit here.

For further information, please contact:

Jayme Maniatis
Philips Global External Relations
Tel.: 617-894-8368
E-mail: jayme.maniatis@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2025 sales of approximately EUR 18 billion and employs approximately 64,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachment

  • Philips Alturion ultrasound system

© 2026 GlobeNewswire (Europe)
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.